Sign in

Viral hepatitis: The silent killer you need to keep at bay

Published on: Nov 29, 2015, 12:36:33 IST
Hindustan Times | By , New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link
One in three persons affected with blood-borne viral hepatitis-B and C in India at a risk of developing liver cancer, yet most of them are not aware of their infection. (Shutterstock)
One in three persons affected with blood-borne viral hepatitis-B and C in India at a risk of developing liver cancer, yet most of them are not aware of their infection. (Shutterstock)

Viral hepatitis — the inflammation of the liver due to infection — is a deadly disease that most people are often not aware of.

Viral hepatitis — the inflammation of the liver due to infection — is a deadly disease that most people are often not aware of. The Delhi government, in order to create awareness among the masses about the disease and its symptoms (that is often mild), celebrates December 4 as Hepatitis day every year.

The government-run Institute of Liver and Biliary Sciences (ILBS) will organise an awareness event on the day this year also. Hepatitis infection is broadly divided into two categories — blood-borne B and C and waterborne A and E.

One in three persons affected with blood-borne viral hepatitis-B and C, are at a risk of developing liver cancer, yet most of them are not aware of their infection. “Chances of developing liver cirrhosis are almost 20% higher in people with blood-borne viral hepatitis. And because the symptoms are so mild that it is easy to miss. The disease is a silent killer,” says Dr SK Sarin, director, ILBS.

Article image

Blood-borne hepatitis B and C infections cause liver damage over time. In most cases, there are no symptoms till the liver is about 75% damaged. Unsafe blood transfusion, tattoos or dental procedures using unsterilised tools, unprotected sex, sharing razor can lead to disease transmission from an infected person to a healthy person. An estimated 25 million to 40 million Indians carry the Hepatitis B and C viruses (HBV and HCV).

There is a vaccine against hepatitis B but the disease has no cure; one needs to be on medicines for their entire life to keep the virus in check. For hepatitis C, there is no vaccine but there is a cure in the form of advanced medicines that are expensive.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More